ID   RIR1_HUMAN              Reviewed;         792 AA.
AC   P23921; Q9UNN2;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-1992, sequence version 1.
DT   28-JUN-2023, entry version 216.
DE   RecName: Full=Ribonucleoside-diphosphate reductase large subunit;
DE            EC=1.17.4.1;
DE   AltName: Full=Ribonucleoside-diphosphate reductase subunit M1;
DE   AltName: Full=Ribonucleotide reductase large subunit;
GN   Name=RRM1; Synonyms=RR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=1840662; DOI=10.1093/nar/19.13.3741;
RA   Parker N.J., Begley C.G., Fox R.M.;
RT   "Human M1 subunit of ribonucleotide reductase: cDNA sequence and expression
RT   in stimulated lymphocytes.";
RL   Nucleic Acids Res. 19:3741-3741(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Mammary carcinoma;
RX   PubMed=1627826; DOI=10.3109/10425179209020807;
RA   Pavloff N., Rivard D., Masson S., Shen S.-H., Mes-Masson A.-M.;
RT   "Sequence analysis of the large and small subunits of human ribonucleotide
RT   reductase.";
RL   DNA Seq. 2:227-234(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9933563; DOI=10.1006/geno.1998.5659;
RA   Bepler G., O'Briant K.C., Kim Y.-C., Schreiber G., Pitterle D.M.;
RT   "A 1.4-Mb high-resolution physical map and contig of chromosome segment
RT   11p15.5 and genes in the LOH11A metastasis suppressor region.";
RL   Genomics 55:164-175(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6.
RC   TISSUE=Placenta;
RX   PubMed=8188248; DOI=10.1006/geno.1994.1017;
RA   Parker N.J., Begley C.G., Fox R.M.;
RT   "Human R1 subunit of ribonucleotide reductase (RRM1): 5' flanking region of
RT   the gene.";
RL   Genomics 19:91-96(1994).
RN   [6]
RP   ACTIVITY REGULATION.
RX   PubMed=1867633; DOI=10.1016/0006-2952(91)90033-2;
RA   Harrington J.A., Spector T.;
RT   "Human ribonucleotide reductase. Activation and inhibition by analogs of
RT   ATP.";
RL   Biochem. Pharmacol. 42:759-763(1991).
RN   [7]
RP   INTERACTION WITH RRM2B.
RX   PubMed=12615712;
RA   Xue L., Zhou B., Liu X., Qiu W., Jin Z., Yen Y.;
RT   "Wild-type p53 regulates human ribonucleotide reductase by protein-protein
RT   interaction with p53R2 as well as hRRM2 subunits.";
RL   Cancer Res. 63:980-986(2003).
RN   [8]
RP   CATALYTIC ACTIVITY, SUBUNIT, AND ACTIVITY REGULATION.
RX   PubMed=16376858; DOI=10.1016/j.bbrc.2005.12.019;
RA   Qiu W., Zhou B., Darwish D., Shao J., Yen Y.;
RT   "Characterization of enzymatic properties of human ribonucleotide reductase
RT   holoenzyme reconstituted in vitro from hRRM1, hRRM2, and p53R2 subunits.";
RL   Biochem. Biophys. Res. Commun. 340:428-434(2006).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17 AND LYS-376, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-751, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   ACTIVITY REGULATION, MUTAGENESIS OF ASP-57, AND INTERACTION WITH AHCYL1.
RX   PubMed=25237103; DOI=10.1126/science.1251550;
RA   Arnaoutov A., Dasso M.;
RT   "Enzyme regulation. IRBIT is a novel regulator of ribonucleotide reductase
RT   in higher eukaryotes.";
RL   Science 345:1512-1515(2014).
RN   [13] {ECO:0007744|PDB:2WGH, ECO:0007744|PDB:3HNC, ECO:0007744|PDB:3HND, ECO:0007744|PDB:3HNE, ECO:0007744|PDB:3HNF}
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 75-742 IN COMPLEX WITH ALLOSTERIC
RP   EFFECTORS ATP; DATP; DTTP; SUBSTRATE GDP AND MAGNESIUM IONS.
RX   PubMed=21336276; DOI=10.1038/nsmb.2007;
RA   Fairman J.W., Wijerathna S.R., Ahmad M.F., Xu H., Nakano R., Jha S.,
RA   Prendergast J., Welin R.M., Flodin S., Roos A., Nordlund P., Li Z.,
RA   Walz T., Dealwis C.G.;
RT   "Structural basis for allosteric regulation of human ribonucleotide
RT   reductase by nucleotide-induced oligomerization.";
RL   Nat. Struct. Mol. Biol. 18:316-322(2011).
CC   -!- FUNCTION: Provides the precursors necessary for DNA synthesis.
CC       Catalyzes the biosynthesis of deoxyribonucleotides from the
CC       corresponding ribonucleotides.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[thioredoxin]-disulfide + a 2'-deoxyribonucleoside 5'-
CC         diphosphate + H2O = [thioredoxin]-dithiol + a ribonucleoside 5'-
CC         diphosphate; Xref=Rhea:RHEA:23252, Rhea:RHEA-COMP:10698, Rhea:RHEA-
CC         COMP:10700, ChEBI:CHEBI:15377, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058,
CC         ChEBI:CHEBI:57930, ChEBI:CHEBI:73316; EC=1.17.4.1;
CC         Evidence={ECO:0000269|PubMed:16376858};
CC   -!- ACTIVITY REGULATION: Under complex allosteric control mediated by
CC       deoxynucleoside triphosphates and ATP binding to separate specificity
CC       and activation sites on the M1 subunit. The type of nucleotide bound at
CC       the specificity site determines substrate preference. It seems probable
CC       that ATP makes the enzyme reduce CDP and UDP, dGTP favors ADP reduction
CC       and dTTP favors GDP reduction. Stimulated by ATP and inhibited by dATP
CC       binding to the activity site, the dATP inhibition is mediated by AHCYL1
CC       which stabilizes dATP in the site. {ECO:0000269|PubMed:16376858,
CC       ECO:0000269|PubMed:1867633, ECO:0000269|PubMed:25237103}.
CC   -!- PATHWAY: Genetic information processing; DNA replication.
CC   -!- SUBUNIT: Heterodimer of a large and a small subunit. Heterodimer with
CC       small subunit RRM2 or RRM2B. The heterodimer with RRM2 has higher
CC       catalytic activity than the heterodimer with RRM2B. Interacts with
CC       AHCYL1 which inhibits its activity. {ECO:0000269|PubMed:16376858,
CC       ECO:0000269|PubMed:21336276, ECO:0000269|PubMed:25237103}.
CC   -!- INTERACTION:
CC       P23921; P23921: RRM1; NbExp=5; IntAct=EBI-717006, EBI-717006;
CC       P23921; P31350: RRM2; NbExp=6; IntAct=EBI-717006, EBI-2339245;
CC       P23921; Q8N720: ZNF655; NbExp=3; IntAct=EBI-717006, EBI-625509;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- MISCELLANEOUS: Two distinct regulatory sites have been defined: the
CC       specificity site, which controls substrate specificity, and the
CC       activity site which regulates overall catalytic activity. A substrate-
CC       binding catalytic site, located on M1, is formed only in the presence
CC       of the second subunit M2.
CC   -!- MISCELLANEOUS: The level of the enzyme activity is closely correlated
CC       with the growth rate of a cell and appears to vary with the cell cycle.
CC   -!- SIMILARITY: Belongs to the ribonucleoside diphosphate reductase large
CC       chain family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Ribonucleotide reductase entry;
CC       URL="https://en.wikipedia.org/wiki/Ribonucleotide_reductase";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/42174/RRM1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X59543; CAA42118.1; -; mRNA.
DR   EMBL; X59617; CAA42180.1; -; mRNA.
DR   EMBL; AF107045; AAD37491.1; -; Genomic_DNA.
DR   EMBL; BC006498; AAH06498.1; -; mRNA.
DR   EMBL; L10342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS7750.1; -.
DR   PIR; S16680; S16680.
DR   RefSeq; NP_001024.1; NM_001033.4.
DR   RefSeq; NP_001304993.1; NM_001318064.1.
DR   RefSeq; NP_001304994.1; NM_001318065.1.
DR   PDB; 2WGH; X-ray; 2.30 A; A/B=75-742.
DR   PDB; 3HNC; X-ray; 2.41 A; A/B=1-792.
DR   PDB; 3HND; X-ray; 3.21 A; A/B=1-792.
DR   PDB; 3HNE; X-ray; 3.11 A; A/B=1-792.
DR   PDB; 3HNF; X-ray; 3.16 A; A/B=1-792.
DR   PDB; 4X3V; X-ray; 3.70 A; A/B=1-792.
DR   PDB; 5D1Y; X-ray; 9.01 A; A/B=1-792.
DR   PDB; 5TUS; X-ray; 2.66 A; A/B=1-792.
DR   PDB; 6AUI; EM; 3.30 A; A/B/C/D/E/F=1-792.
DR   PDB; 6L3R; X-ray; 2.00 A; A/E=75-742.
DR   PDB; 6L7L; X-ray; 2.17 A; A/E=75-742.
DR   PDB; 6LKM; X-ray; 2.55 A; A/B=75-742.
DR   PDBsum; 2WGH; -.
DR   PDBsum; 3HNC; -.
DR   PDBsum; 3HND; -.
DR   PDBsum; 3HNE; -.
DR   PDBsum; 3HNF; -.
DR   PDBsum; 4X3V; -.
DR   PDBsum; 5D1Y; -.
DR   PDBsum; 5TUS; -.
DR   PDBsum; 6AUI; -.
DR   PDBsum; 6L3R; -.
DR   PDBsum; 6L7L; -.
DR   PDBsum; 6LKM; -.
DR   AlphaFoldDB; P23921; -.
DR   SMR; P23921; -.
DR   BioGRID; 112154; 137.
DR   ComplexPortal; CPX-2194; Ribonucleoside-diphosphate reductase RR1 complex, RRM2 variant.
DR   ComplexPortal; CPX-369; Ribonucleoside-diphosphate reductase RR1 complex, RRM2B variant.
DR   DIP; DIP-24233N; -.
DR   IntAct; P23921; 28.
DR   MINT; P23921; -.
DR   STRING; 9606.ENSP00000300738; -.
DR   BindingDB; P23921; -.
DR   ChEMBL; CHEMBL1830; -.
DR   DrugBank; DB00242; Cladribine.
DR   DrugBank; DB00631; Clofarabine.
DR   DrugBank; DB01073; Fludarabine.
DR   DrugBank; DB05420; Gallium maltolate.
DR   DrugBank; DB00441; Gemcitabine.
DR   DrugBank; DB01005; Hydroxyurea.
DR   DrugBank; DB05003; Imexon.
DR   DrugBank; DB06433; Tezacitabine.
DR   DrugCentral; P23921; -.
DR   GuidetoPHARMACOLOGY; 2630; -.
DR   GlyCosmos; P23921; 4 sites, 1 glycan.
DR   GlyGen; P23921; 6 sites, 1 O-linked glycan (6 sites).
DR   iPTMnet; P23921; -.
DR   MetOSite; P23921; -.
DR   PhosphoSitePlus; P23921; -.
DR   SwissPalm; P23921; -.
DR   BioMuta; RRM1; -.
DR   DMDM; 132608; -.
DR   EPD; P23921; -.
DR   jPOST; P23921; -.
DR   MassIVE; P23921; -.
DR   MaxQB; P23921; -.
DR   PaxDb; P23921; -.
DR   PeptideAtlas; P23921; -.
DR   ProteomicsDB; 54166; -.
DR   Antibodypedia; 10853; 738 antibodies from 38 providers.
DR   DNASU; 6240; -.
DR   Ensembl; ENST00000300738.10; ENSP00000300738.5; ENSG00000167325.15.
DR   GeneID; 6240; -.
DR   KEGG; hsa:6240; -.
DR   MANE-Select; ENST00000300738.10; ENSP00000300738.5; NM_001033.5; NP_001024.1.
DR   UCSC; uc001lyw.5; human.
DR   AGR; HGNC:10451; -.
DR   CTD; 6240; -.
DR   DisGeNET; 6240; -.
DR   GeneCards; RRM1; -.
DR   HGNC; HGNC:10451; RRM1.
DR   HPA; ENSG00000167325; Low tissue specificity.
DR   MIM; 180410; gene.
DR   neXtProt; NX_P23921; -.
DR   OpenTargets; ENSG00000167325; -.
DR   PharmGKB; PA298; -.
DR   VEuPathDB; HostDB:ENSG00000167325; -.
DR   eggNOG; KOG1112; Eukaryota.
DR   GeneTree; ENSGT00910000144246; -.
DR   HOGENOM; CLU_000404_1_0_1; -.
DR   InParanoid; P23921; -.
DR   OMA; RGSIQNI; -.
DR   OrthoDB; 5472715at2759; -.
DR   PhylomeDB; P23921; -.
DR   TreeFam; TF300578; -.
DR   BioCyc; MetaCyc:HS09541-MON; -.
DR   BRENDA; 1.17.4.1; 2681.
DR   PathwayCommons; P23921; -.
DR   Reactome; R-HSA-499943; Interconversion of nucleotide di- and triphosphates.
DR   SignaLink; P23921; -.
DR   SIGNOR; P23921; -.
DR   UniPathway; UPA00326; -.
DR   BioGRID-ORCS; 6240; 845 hits in 1174 CRISPR screens.
DR   ChiTaRS; RRM1; human.
DR   EvolutionaryTrace; P23921; -.
DR   GeneWiki; RRM1; -.
DR   GenomeRNAi; 6240; -.
DR   Pharos; P23921; Tclin.
DR   PRO; PR:P23921; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P23921; protein.
DR   Bgee; ENSG00000167325; Expressed in ventricular zone and 215 other tissues.
DR   ExpressionAtlas; P23921; baseline and differential.
DR   Genevisible; P23921; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005971; C:ribonucleoside-diphosphate reductase complex; IPI:ComplexPortal.
DR   GO; GO:0005524; F:ATP binding; IBA:GO_Central.
DR   GO; GO:0097718; F:disordered domain specific binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0061731; F:ribonucleoside-diphosphate reductase activity; IMP:CACAO.
DR   GO; GO:0004748; F:ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ISS:UniProtKB.
DR   GO; GO:0009265; P:2'-deoxyribonucleotide biosynthetic process; IDA:ComplexPortal.
DR   GO; GO:0009263; P:deoxyribonucleotide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IDA:ComplexPortal.
DR   GO; GO:0000731; P:DNA synthesis involved in DNA repair; NAS:ComplexPortal.
DR   GO; GO:0006264; P:mitochondrial DNA replication; IMP:ComplexPortal.
DR   GO; GO:0070318; P:positive regulation of G0 to G1 transition; IDA:ComplexPortal.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IDA:ComplexPortal.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IDA:ComplexPortal.
DR   GO; GO:0051290; P:protein heterotetramerization; IEA:Ensembl.
DR   GO; GO:0009185; P:ribonucleoside diphosphate metabolic process; IDA:ComplexPortal.
DR   CDD; cd01679; RNR_I; 1.
DR   Gene3D; 3.20.70.20; -; 1.
DR   InterPro; IPR005144; ATP-cone_dom.
DR   InterPro; IPR013346; NrdE_NrdA_C.
DR   InterPro; IPR000788; RNR_lg_C.
DR   InterPro; IPR013509; RNR_lsu_N.
DR   InterPro; IPR008926; RNR_R1-su_N.
DR   InterPro; IPR039718; Rrm1.
DR   PANTHER; PTHR11573; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE CHAIN; 1.
DR   PANTHER; PTHR11573:SF6; RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE LARGE SUBUNIT; 1.
DR   Pfam; PF03477; ATP-cone; 1.
DR   Pfam; PF02867; Ribonuc_red_lgC; 1.
DR   Pfam; PF00317; Ribonuc_red_lgN; 1.
DR   PRINTS; PR01183; RIBORDTASEM1.
DR   SUPFAM; SSF51998; PFL-like glycyl radical enzymes; 1.
DR   SUPFAM; SSF48168; R1 subunit of ribonucleotide reductase, N-terminal domain; 1.
DR   PROSITE; PS51161; ATP_CONE; 1.
DR   PROSITE; PS00089; RIBORED_LARGE; 1.
DR   TIGRFAMs; TIGR02506; NrdE_NrdA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Allosteric enzyme; ATP-binding; Cytoplasm;
KW   Deoxyribonucleotide synthesis; Disulfide bond; Nucleotide-binding;
KW   Oxidoreductase; Phosphoprotein; Reference proteome.
FT   CHAIN           1..792
FT                   /note="Ribonucleoside-diphosphate reductase large subunit"
FT                   /id="PRO_0000187190"
FT   DOMAIN          1..92
FT                   /note="ATP-cone"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00492"
FT   ACT_SITE        427
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        429
FT                   /note="Cysteine radical intermediate"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        431
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   BINDING         5..6
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         11..17
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         53
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         57
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /ligand_note="allosteric activator"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         202
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0007744|PDB:3HND"
FT   BINDING         217
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0007744|PDB:3HND"
FT   BINDING         226..228
FT                   /ligand="dTTP"
FT                   /ligand_id="ChEBI:CHEBI:37568"
FT                   /ligand_note="allosteric effector that controls substrate
FT                   specificity"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         243
FT                   /ligand="dTTP"
FT                   /ligand_id="ChEBI:CHEBI:37568"
FT                   /ligand_note="allosteric effector that controls substrate
FT                   specificity"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         256
FT                   /ligand="dTTP"
FT                   /ligand_id="ChEBI:CHEBI:37568"
FT                   /ligand_note="allosteric effector that controls substrate
FT                   specificity"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         263..264
FT                   /ligand="dTTP"
FT                   /ligand_id="ChEBI:CHEBI:37568"
FT                   /ligand_note="allosteric effector that controls substrate
FT                   specificity"
FT                   /evidence="ECO:0007744|PDB:3HNE"
FT   BINDING         427
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0007744|PDB:3HND"
FT   BINDING         431
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0007744|PDB:3HND"
FT   BINDING         604..607
FT                   /ligand="GDP"
FT                   /ligand_id="ChEBI:CHEBI:58189"
FT                   /evidence="ECO:0007744|PDB:3HND"
FT   SITE            218
FT                   /note="Important for hydrogen atom transfer"
FT                   /evidence="ECO:0000250"
FT   SITE            444
FT                   /note="Important for hydrogen atom transfer"
FT                   /evidence="ECO:0000250"
FT   SITE            737
FT                   /note="Important for electron transfer"
FT                   /evidence="ECO:0000250"
FT   SITE            738
FT                   /note="Important for electron transfer"
FT                   /evidence="ECO:0000250"
FT   SITE            787
FT                   /note="Interacts with thioredoxin/glutaredoxin"
FT                   /evidence="ECO:0000250"
FT   SITE            790
FT                   /note="Interacts with thioredoxin/glutaredoxin"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         17
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         376
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         751
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   DISULFID        218..444
FT                   /note="Redox-active"
FT                   /evidence="ECO:0000250"
FT   VARIANT         590
FT                   /note="K -> Q (in dbSNP:rs2228123)"
FT                   /id="VAR_052052"
FT   VARIANT         778
FT                   /note="V -> A (in dbSNP:rs2229196)"
FT                   /id="VAR_052053"
FT   MUTAGEN         57
FT                   /note="D->N: Severely decreases interaction with AHCYL1 in
FT                   the presence of dATP."
FT                   /evidence="ECO:0000269|PubMed:25237103"
FT   CONFLICT        6
FT                   /note="R -> Q (in Ref. 3; AAD37491)"
FT                   /evidence="ECO:0000305"
FT   STRAND          2..4
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   TURN            6..8
FT                   /evidence="ECO:0007829|PDB:6AUI"
FT   STRAND          10..12
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   HELIX           15..23
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   HELIX           24..26
FT                   /evidence="ECO:0007829|PDB:6AUI"
FT   TURN            31..33
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   HELIX           36..44
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   STRAND          48..50
FT                   /evidence="ECO:0007829|PDB:3HND"
FT   HELIX           53..66
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   HELIX           67..69
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   HELIX           76..88
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           94..103
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   TURN            107..109
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           118..126
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           128..134
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           137..142
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           145..154
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          158..163
FT                   /evidence="ECO:0007829|PDB:3HNF"
FT   HELIX           167..179
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           183..194
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          197..200
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           202..207
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          210..212
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          218..222
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           228..243
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          247..251
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          258..261
FT                   /evidence="ECO:0007829|PDB:3HNE"
FT   TURN            263..266
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          268..270
FT                   /evidence="ECO:0007829|PDB:3HNE"
FT   HELIX           272..285
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          286..288
FT                   /evidence="ECO:0007829|PDB:6AUI"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:6LKM"
FT   STRAND          297..301
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           308..311
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   TURN            312..315
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           321..323
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          328..334
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           336..343
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          347..351
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   TURN            353..355
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           359..361
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           364..376
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          381..385
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           386..400
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          404..407
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           408..413
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           418..420
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          428..430
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   STRAND          442..444
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          446..450
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           451..454
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          459..461
FT                   /evidence="ECO:0007829|PDB:3HND"
FT   HELIX           463..483
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           489..498
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          502..506
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           508..514
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          519..521
FT                   /evidence="ECO:0007829|PDB:6LKM"
FT   HELIX           522..550
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           554..556
FT                   /evidence="ECO:0007829|PDB:3HNE"
FT   HELIX           561..563
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           567..570
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          577..579
FT                   /evidence="ECO:0007829|PDB:2WGH"
FT   HELIX           581..591
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           605..611
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          615..618
FT                   /evidence="ECO:0007829|PDB:6AUI"
FT   STRAND          623..625
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          632..637
FT                   /evidence="ECO:0007829|PDB:3HNC"
FT   HELIX           639..647
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           655..661
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   TURN            662..664
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           666..668
FT                   /evidence="ECO:0007829|PDB:6AUI"
FT   STRAND          670..672
FT                   /evidence="ECO:0007829|PDB:6L7L"
FT   HELIX           674..679
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           683..685
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   HELIX           688..699
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          709..711
FT                   /evidence="ECO:0007829|PDB:6AUI"
FT   HELIX           717..729
FT                   /evidence="ECO:0007829|PDB:6L3R"
FT   STRAND          733..737
FT                   /evidence="ECO:0007829|PDB:6L3R"
SQ   SEQUENCE   792 AA;  90070 MW;  4470A76C61E8F86A CRC64;
     MHVIKRDGRQ ERVMFDKITS RIQKLCYGLN MDFVDPAQIT MKVIQGLYSG VTTVELDTLA
     AETAATLTTK HPDYAILAAR IAVSNLHKET KKVFSDVMED LYNYINPHNG KHSPMVAKST
     LDIVLANKDR LNSAIIYDRD FSYNYFGFKT LERSYLLKIN GKVAERPQHM LMRVSVGIHK
     EDIDAAIETY NLLSERWFTH ASPTLFNAGT NRPQLSSCFL LSMKDDSIEG IYDTLKQCAL
     ISKSAGGIGV AVSCIRATGS YIAGTNGNSN GLVPMLRVYN NTARYVDQGG NKRPGAFAIY
     LEPWHLDIFE FLDLKKNTGK EEQRARDLFF ALWIPDLFMK RVETNQDWSL MCPNECPGLD
     EVWGEEFEKL YASYEKQGRV RKVVKAQQLW YAIIESQTET GTPYMLYKDS CNRKSNQQNL
     GTIKCSNLCT EIVEYTSKDE VAVCNLASLA LNMYVTSEHT YDFKKLAEVT KVVVRNLNKI
     IDINYYPVPE ACLSNKRHRP IGIGVQGLAD AFILMRYPFE SAEAQLLNKQ IFETIYYGAL
     EASCDLAKEQ GPYETYEGSP VSKGILQYDM WNVTPTDLWD WKVLKEKIAK YGIRNSLLIA
     PMPTASTAQI LGNNESIEPY TSNIYTRRVL SGEFQIVNPH LLKDLTERGL WHEEMKNQII
     ACNGSIQSIP EIPDDLKQLY KTVWEISQKT VLKMAAERGA FIDQSQSLNI HIAEPNYGKL
     TSMHFYGWKQ GLKTGMYYLR TRPAANPIQF TLNKEKLKDK EKVSKEEEEK ERNTAAMVCS
     LENRDECLMC GS
//
